Ritesh Maharaj is a critical care physician at King’s College Hospital, London with previous teaching experience at the King’s College London School of Medicine. His research focuses on the organization of health services and its impact on health outcomes. He focuses on critical care services and the effects of centralization, specialization and organizational learning. He is currently researching the supply of critical care services and its impact on mortality.

Astrid Van Wilder has a background in pharmaceutical sciences, in which she obtained her MSc in 2016 at KU Leuven (Belgium) after a research stay at UCL School of Pharmacy (UK). While practicing pharmacy, she developed an interest in healthcare policy and patient safety, leading to the obtainment of an MSc in Healthcare Policy and Management in 2017 (KU Leuven, Belgium) and a PhD in Biomedical Sciences in 2023 (KU Leuven, Belgium) focusing on nationwide variability in patient outcomes across Belgian hospitals. Her current research at Brown University School of Public Health focuses on differences in health service organization, both within and across countries, and their impact on patient outcomes.

Viktoria Steinbeck is a 2024–25 Harkness Fellow in Health Care Policy and Practice funded by the Commonwealth Fund. Her research focuses on the use of patient-reported outcomes to assess the quality of care and value-based healthcare (VBHC). Her research has been published in research outlets including JAMA Network Open, Value in Health, and others. As co-creator of the first VBHC course for German-speaking countries, she is engaged in teaching interdisciplinary cohorts about aligning incentives to achieve outcomes that matter to patients. She earned a PhD in Health Economics at the Berlin University of Technology, a Double MSc, in Health Economics and Management at Maastricht and Cologne University and a BSc in European Public Health at Maastricht University including research stays at Columbia University New York and Metropolitan University College Copenhagen. Steinbeck gained previous work experience with a variety of health care stakeholders, including the European Commission, Allianz Insurance and as an EU policy consultant in Brussels.

Jean Pierre is a PhD Candidate in Health Systems and Policy at the University of Bern, Switzerland. His PhD tackles health policy issues that affect both advanced and developing health systems such as health inequities, health care cost containment and the global pursuit of universal health coverage. As a Visiting Research Fellow at Brown, Jean Pierre is conducting an international comparison of unexplored dimensions of out of pocket health expenses. Jean Pierre is also Research Associate at the Swiss institute for translational and entrepreneurial medicine (sitem-insel, Switzerland) where he collaborates with local and foreign startups, as well as established pharmaceutical companies to generate translational evidence in a variety of areas including reimbursement policy, cost-effectiveness of new medical technologies and clinical trial data collection. Jean Pierre holds a Master’s degree in Economics from HEC Lausanne, Université de Lausanne.

Jonathan Cylus is the head of the London Hubs of the European Observatory on Health Systems and Policies and a Senior Research Fellow at LSE Health. His main research is on health systems, focusing primarily on health financing policy, health economics and health system performance. He has worked on these topics in a number of countries, including Cyprus, Liberia, Finland, Malta, Mexico, Moldova, Slovenia and the United States, as well as with the European Commission, OECD and WHO. Jon is also interested in the role of social policies and other social determinants on health. Prior to joining the Observatory, Jonathan was an economist at the Centers for Medicare and Medicaid Services (CMS) in the United States where he worked on health care expenditure projections, hospital productivity, and health care expenditure estimates by age and gender.

Ilias Kyriopoulos is an Assistant Professor in the Department of Health Policy at LSE and the Programme Co-Director of the MSc in Health Data Science. He previously worked as a Fellow and Research Associate at LSE. Prior to joining the Department, he was a Health Economist at the Athens School of Public Health. Ilias has also conducted research for or acted as a consultant to international governmental and non-governmental organisations, including the European Commission, the United Nations Development Programme, and the World Bank. Ilias's research mainly focuses on how economic uncertainty and policy impact population health and health systems. His interests also include inequalities in health and health care and the economics of mental health and well-being. His work has been published in various journals, including Journal of the Royal Statistical Society, Health Economics, Social Science & Medicine, The Milbank Quarterly, Journal of Epidemiology & Community Health etc.

Mylene Lagarde is Associate Professor of Health Economics and Deputy Head of Department (Research) in the Department of Health Policy. In her research, Mylene uses applied economic analysis and a range of empirical methods to understand the drivers of individual decisions made by patients as well as providers, with a view to inform current health policy debates in low- and middle income countries. She is particularly interested in exploring the determinants of providers’ performance and the demand for healthcare services.

Huseyin Naci is an Associate Professor in the Department of Health Policy at the London School of Economics and Political Science (LSE). Huseyin serves as co-director of LSE’s Executive Master of Science program in Health Economics, Outcomes and Management in Clinical Sciences. He is also one of the Deputy Directors of LSE Health. Huseyin’s research evaluates the quantity and quality of the evidence base underpinning the approval, adoption, reimbursement, and use of new pharmaceutical products in Europe and the US. His research has appeared in leading medical and health policy journals, including JAMA, The Lancet, The BMJ, Health Affairs, and The Milbank Quarterly. His 2013 article comparing the mortality benefits of drug and non-drug interventions for common chronic conditions was selected as one of the “Five key BMJ research papers to mark the decade.” In 2020, Huseyin jointly led the development of the Lancet Series on Comparative Effectiveness, which identified the shortcomings of the current research landscape on new drugs both before and after approval, and outlined key changes to the regulatory system that would be required to ensure that patients, clinicians, and payers have timely access to the data they need for decision making.

Liana Woskie is an Assistant Professor in the Department of Community Health at Tufts University and an Adjunct Assistant Professor of Health Services, Policy and Practice at the Brown University School of Public Health. Liana evaluates health system performance and the degree to which systems are held accountable to patients. Her dissertation (not yet published) provides the first quantification of a World Health Organization human rights framework on eliminating coercive female sterilization. She generates contemporary estimates of the prevalence and drivers of uninformed tubal ligation and uses quasi-experimental methods to assess health policies that effect female sterilization practice patterns. Her project: "Quantifying Structural Violence: Female Sterilization and Normalized State Repression in Healthcare," was awarded a H. F. Guggenheim Emerging Scholar Award for research on causes and manifestations of violence against women and the Horowitz Foundation Trustees' Award for most innovative approach to theory and/or methodology.

Olivier J. Wouters is an Assistant Professor of Health Policy at the London School of Economics and Political Science (LSE), where he directs the Master of Science program in Global Health Policy. Olivier researches and teaches about the pricing and affordability of medicines internationally. He has previously conducted research on the cost of drug development and the political influence of the pharmaceutical lobby. His work has been published in leading health policy and medical journals, including JAMA, The Lancet, The Milbank Quarterly, and NEJM. In 2021, Olivier was awarded LSE’s Excellence in Education Award for “Outstanding Teaching Contribution and Educational Leadership”.